» Articles » PMID: 30197980

Prevalence and Risk Factors for CKD: A Comparison Between the Adult Populations in China and the United States

Overview
Journal Kidney Int Rep
Publisher Elsevier
Specialty Nephrology
Date 2018 Sep 11
PMID 30197980
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Chronic kidney disease (CKD) is an important noncommunicable disease globally. Overall prevalence of CKD and distribution of its stages differ between countries. We postulate that these differences may not only be due to variation in prevalence of risk factors but also their differential impact in different populations or settings.

Methods: We used nationally representative data on the adult populations from both the United States (US; National Health and Nutrition Examination Survey [NHANES], 2009 to 2010, N = 5557) and China (China National Survey of CKD, 2009 to 2010, N = 46,949). Age, sex, central obesity, cardiovascular disease, diabetes, hypertension, and hyperuricemia were explored as candidate risk factors for CKD. The prevalence of CKD was calculated using survey weights.

Results: The prevalence of decreased estimated glomerular filtration rate (eGFR), defined as eGFR < 60 ml/min per 1.73 m, was 6.5% in the US versus 2.7% in China, whereas the prevalence of albuminuria (defined as urine albumin to creatinine ratio of ≥30 mg/g) was 8.1% in the US versus 9.5% in China. The distribution of eGFR categories differed between the countries ( < 0.001). Stronger associations of diabetes with both indicators were seen in the US participants, whereas stronger associations of male sex with both indicators and of hypertension with albuminuria were observed in the Chinese participants ( < 0.05). After multivariable adjustment, a 65% change in prevalence difference for decreased eGFR was seen between China and the US.

Conclusion: People in China and the US share many common risk factors for CKD, but differences in prevalence and the potential impact of these risk factors for CKD were observed.

Citing Articles

Development of risk models for early detection and prediction of chronic kidney disease in clinical settings.

Bahrami P, Tanbakuchi D, Afzalaghaee M, Ghayour-Mobarhan M, Esmaily H Sci Rep. 2024; 14(1):32136.

PMID: 39739001 PMC: 11685774. DOI: 10.1038/s41598-024-83973-5.


Prevalence of associated renal risk in type 2 diabetes mellitus in the United Arab Emirates.

Ahmed M, Ali O, Naqvi S, Ahmed A, Omar W J Diabetes. 2024; 16(12):e70038.

PMID: 39697051 PMC: 11656030. DOI: 10.1111/1753-0407.70038.


Albuminuria Prevalence in Fontan Patients: A Systematic Review and Meta-Analysis.

Van Belle H, Van den Eynde J, Cieplucha A, Ladouceur M, Martinod K, Pierard S Pediatr Cardiol. 2024; .

PMID: 39688686 DOI: 10.1007/s00246-024-03736-x.


Association of dementia with impaired kidney function and plasma biomarkers: A population-based study.

Wang N, Ma Y, Liang X, Fa W, Tian X, Liu C Eur J Neurol. 2024; 31(12):e16488.

PMID: 39331367 PMC: 11555029. DOI: 10.1111/ene.16488.


Effects of soluble Klotho and Wnt/β-catenin signaling pathway in vascular calcification in chronic kidney disease model rats and the intervention of Shenyuan granules.

Zou X, Wang C, Wang L, Huang S, Deng D, Lin L Ren Fail. 2024; 46(2):2394633.

PMID: 39230198 PMC: 11376303. DOI: 10.1080/0886022X.2024.2394633.


References
1.
Pan X, Yang W, Li G, Liu J . Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care. 1997; 20(11):1664-9. DOI: 10.2337/diacare.20.11.1664. View

2.
Soderland P, Lovekar S, Weiner D, Brooks D, Kaufman J . Chronic kidney disease associated with environmental toxins and exposures. Adv Chronic Kidney Dis. 2010; 17(3):254-64. DOI: 10.1053/j.ackd.2010.03.011. View

3.
Lee S, Kim Y, Oh S, Koo H, Na K, Chae D . Trends in the prevalence of chronic kidney disease, other chronic diseases and health-related behaviors in an adult Korean population: data from the Korean National Health and Nutrition Examination Survey (KNHANES). Nephrol Dial Transplant. 2011; 26(12):3975-80. DOI: 10.1093/ndt/gfr154. View

4.
Wang J, Zhang L, Wang F, Liu L, Wang H . Prevalence, awareness, treatment, and control of hypertension in China: results from a national survey. Am J Hypertens. 2014; 27(11):1355-61. PMC: 4263934. DOI: 10.1093/ajh/hpu053. View

5.
Haynes R, Staplin N, Emberson J, Herrington W, Tomson C, Agodoa L . Evaluating the contribution of the cause of kidney disease to prognosis in CKD: results from the Study of Heart and Renal Protection (SHARP). Am J Kidney Dis. 2014; 64(1):40-8. PMC: 4068325. DOI: 10.1053/j.ajkd.2013.12.013. View